KRAS G12C Mutant Advanced Solid Tumors
2 clinical trials · Condition
◉ Watch KRAS G12C Mutant Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases (NCT07581912) | Zhejiang University | 2026-04-30 |
| A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors. (NCT06237400) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-05-26 |
Track KRAS G12C Mutant Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.